
Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2024-2030
Description
Bone Marrow Transplantation Market by Type (Allogeneic Transplant, Autologous Transplant), Treatment Type (Aplastic Anemia, Leukemia, Lymphoma), End-User - Global Forecast 2024-2030
The Bone Marrow Transplantation Market size was estimated at USD 16.27 billion in 2023 and expected to reach USD 17.62 billion in 2024, at a CAGR 8.74% to reach USD 29.26 billion by 2030.
Global Bone Marrow Transplantation Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Bone Marrow Transplantation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bone Marrow Transplantation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Bone Marrow Transplantation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Type Culture Collection, Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Eli Lilly and Company, FUJIFILM Cellular Dynamics, Inc., Gamida Cell, Hemacare Corporation, Lifeline Cell Technology, Lonza Group AG, Magenta Therapeutics, Inc., Merck KgaA, Mesoblast Ltd., Novartis AG, PromoCell GmbH, Qiagen N.V., ReeLabs Pvt. Ltd., Sanofi-Aventis LLC, ScienCell Research Laboratories, Inc., and STEMCELL Technologies Inc..
Market Segmentation & Coverage
This research report categorizes the Bone Marrow Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Allogeneic Transplant
Autologous Transplant
Treatment Type
Aplastic Anemia
Leukemia
Lymphoma
Myelodysplastic Syndrome
Myeloma
Myeloproliferative Disorders
Sickle cell Anemia
Solid Tumors
Thalassemia
End-User
Ambulatory Surgical Centers
Hospitals
Multi-Specialty Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Bone Marrow Transplantation Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bone Marrow Transplantation Market?
3. What are the technology trends and regulatory frameworks in the Bone Marrow Transplantation Market?
4. What is the market share of the leading vendors in the Bone Marrow Transplantation Market?
5. Which modes and strategic moves are suitable for entering the Bone Marrow Transplantation Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
196 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Bone Marrow Transplantation Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
- 5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
- 5.1.1.3. Government initiatives to improve awareness of the therapy
- 5.1.2. Restraints
- 5.1.2.1. High cost of the treatment and lack of reimbursement
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancements in bone marrow transplantation therapy
- 5.1.3.2. Ongoing research & development activities of BMT
- 5.1.4. Challenges
- 5.1.4.1. Concerns related to GVHD, infections and relapse
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Bone Marrow Transplantation Market, by Type
- 6.1. Introduction
- 6.2. Allogeneic Transplant
- 6.3. Autologous Transplant
- 7. Bone Marrow Transplantation Market, by Treatment Type
- 7.1. Introduction
- 7.2. Aplastic Anemia
- 7.3. Leukemia
- 7.4. Lymphoma
- 7.5. Myelodysplastic Syndrome
- 7.6. Myeloma
- 7.7. Myeloproliferative Disorders
- 7.8. Sickle cell Anemia
- 7.9. Solid Tumors
- 7.10. Thalassemia
- 8. Bone Marrow Transplantation Market, by End-User
- 8.1. Introduction
- 8.2. Ambulatory Surgical Centers
- 8.3. Hospitals
- 8.4. Multi-Specialty Clinics
- 9. Americas Bone Marrow Transplantation Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Bone Marrow Transplantation Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Bone Marrow Transplantation Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. American Type Culture Collection
- 13.1.3. Bayer AG
- 13.1.4. Becton, Dickinson and Company
- 13.1.5. Bio-Rad Laboratories, Inc.
- 13.1.6. Bristol Myers Squibb
- 13.1.7. Eli Lilly and Company
- 13.1.8. FUJIFILM Cellular Dynamics, Inc.
- 13.1.9. Gamida Cell
- 13.1.10. Hemacare Corporation
- 13.1.11. Lifeline Cell Technology
- 13.1.12. Lonza Group AG
- 13.1.13. Magenta Therapeutics, Inc.
- 13.1.14. Merck KgaA
- 13.1.15. Mesoblast Ltd.
- 13.1.16. Novartis AG
- 13.1.17. PromoCell GmbH
- 13.1.18. Qiagen N.V.
- 13.1.19. ReeLabs Pvt. Ltd.
- 13.1.20. Sanofi-Aventis LLC
- 13.1.21. ScienCell Research Laboratories, Inc.
- 13.1.22. STEMCELL Technologies Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
- FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
- FIGURE 7. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
- FIGURE 10. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.